-
1
-
-
0037043658
-
Inflammatory bowel disease
-
Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-29
-
(2002)
N Engl J Med
, vol.347
, pp. 417-429
-
-
Podolsky, D.K.1
-
3
-
-
9344257937
-
Increased gut permeability in Crohn's disease: Is TNF the link?
-
Gibson PR. Increased gut permeability in Crohn's disease: is TNF the link? Gut. 2001;53:1724-5.
-
(2001)
Gut
, vol.53
, pp. 1724-1725
-
-
Gibson, P.R.1
-
4
-
-
85046530092
-
Clinical implications of delayed orocecal transit time and bacterial overgrowth in adult patients with Crohn's disease
-
Tursi A. Clinical implications of delayed orocecal transit time and bacterial overgrowth in adult patients with Crohn's disease. J Clin Gastroenterol. 2001;32:274-5.
-
(2001)
J Clin Gastroenterol
, vol.32
, pp. 274-275
-
-
Tursi, A.1
-
5
-
-
36549063053
-
Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: A cost-effectiveness analysis
-
Kaplan GG, Hur C, Korzenik J, Sands BE. Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2007;26:1509-20.
-
(2007)
Aliment Pharmacol Ther
, vol.26
, pp. 1509-1520
-
-
Kaplan, G.G.1
Hur, C.2
Korzenik, J.3
Sands, B.E.4
-
6
-
-
32044451548
-
Human anti-tumor necrosis factor monoclonal antibody (Adalimumab) in Crohn's disease: The CLASSIC-I trial
-
Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, Macintosh D, Panaccione R, Wolf D, Pollack P. Human anti-tumor necrosis factor monoclonal antibody (Adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology. 2006;130:323-33.
-
(2006)
Gastroenterology
, vol.130
, pp. 323-333
-
-
Hanauer, S.B.1
Sandborn, W.J.2
Rutgeerts, P.3
Fedorak, R.N.4
Lukas, M.5
Macintosh, D.6
Panaccione, R.7
Wolf, D.8
Pollack, P.9
-
7
-
-
33846242958
-
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
-
Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, Schreiber S, Byczkowski D, Li J, Kent JD, Pollack PF. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology. 2007;132:52-65.
-
(2007)
Gastroenterology
, vol.132
, pp. 52-65
-
-
Colombel, J.F.1
Sandborn, W.J.2
Rutgeerts, P.3
Enns, R.4
Hanauer, S.B.5
Panaccione, R.6
Schreiber, S.7
Byczkowski, D.8
Li, J.9
Kent, J.D.10
Pollack, P.F.11
-
8
-
-
17144388945
-
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease
-
Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005;128:862-9.
-
(2005)
Gastroenterology
, vol.128
, pp. 862-869
-
-
Lichtenstein, G.R.1
Yan, S.2
Bala, M.3
Blank, M.4
Sands, B.E.5
-
9
-
-
0028071632
-
Oral budesonide for active Crohn's disease. Canadian Bowel Disease Study Group
-
Inflammatory
-
Inflammatory Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson AB, Williams CN, Nilsson LG, Persson T. Oral budesonide for active Crohn's disease. Canadian Bowel Disease Study Group. N Engl J Med. 1994;29;331:836-41.
-
(1994)
N Engl J Med
, vol.29
, Issue.331
, pp. 836-841
-
-
Greenberg, G.R.1
Feagan, B.G.2
Martin, F.3
Sutherland, L.R.4
Thomson, A.B.5
Williams, C.N.6
Nilsson, L.G.7
Persson, T.8
-
10
-
-
77955008512
-
Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease
-
Sandborn W, Sutherland L, Pearson D, May G, Modigliani R, Prantera C. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst 000:CD000545.
-
Cochrane Database Syst 000:CD000545
-
-
Sandborn, W.1
Sutherland, L.2
Pearson, D.3
May, G.4
Modigliani, R.5
Prantera, C.6
-
11
-
-
0034214336
-
Comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators
-
Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med. 2000;342:1627-32.
-
(2000)
N Engl J Med
, vol.342
, pp. 1627-1632
-
-
Feagan, B.G.1
Fedorak, R.N.2
Irvine, E.J.3
Wild, G.4
Sutherland, L.5
Steinhart, A.H.6
Greenberg, G.R.7
Koval, J.8
Wong, C.J.9
Hopkins, M.10
Hanauer, S.B.11
McDonald, J.W.A.12
-
12
-
-
0037018761
-
ACCENT I Study Group. Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial
-
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P, ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359:1541-9.
-
(2002)
Lancet
, vol.359
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
Mayer, L.F.4
Schreiber, S.5
Colombel, J.F.6
Rachmilewitz, D.7
Wolf, D.C.8
Olson, A.9
Bao, W.10
Rutgeerts, P.11
-
13
-
-
0036278519
-
The efficacy of azathioprine for the treatment of inflammatory bowel disease: A 30 year review
-
Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 2002;50:485-9.
-
(2002)
Gut
, vol.50
, pp. 485-489
-
-
Fraser, A.G.1
Orchard, T.R.2
Jewell, D.P.3
-
14
-
-
0021358010
-
European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
-
Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, Jesdinsky H. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology. 1984;86:249-66.
-
(1984)
Gastroenterology
, vol.86
, pp. 249-266
-
-
Malchow, H.1
Ewe, K.2
Brandes, J.W.3
Goebell, H.4
Ehms, H.5
Sommer, H.6
Jesdinsky, H.7
-
15
-
-
34248158607
-
Refractory perineal fistulas in Crohn's disease
-
Atienza P. Refractory perineal fistulas in Crohn's disease. Gastroenterol Clin Biol. 2007;31:404-11.
-
(2007)
Gastroenterol Clin Biol
, vol.31
, pp. 404-411
-
-
Atienza, P.1
-
16
-
-
0025274512
-
Prediction of mortality by logistic regression analysis in patients with postoperative enterocutaneousfístula
-
Altomare DF, Serio G, Pannarale OC, Lupo C, Palasciano N, Memeo V, Rubino M. Prediction of mortality by logistic regression analysis in patients with postoperative enterocutaneousfístula. Br J Surg. 1990;77:450-3.
-
(1990)
Br J Surg
, vol.77
, pp. 450-453
-
-
Altomare, D.F.1
Serio, G.2
Pannarale, O.C.3
Lupo, C.4
Palasciano, N.5
Memeo, V.6
Rubino, M.7
-
17
-
-
0016822843
-
Fistulas of the gastrointestinal tract: Experience with eighty-one cases
-
Athanassiades S, Notis P, Toutans C. Fistulas of the gastrointestinal tract: Experience with eighty-one cases. Am J Surg. 1975;130:26-8.
-
(1975)
Am J Surg
, vol.130
, pp. 26-28
-
-
Athanassiades, S.1
Notis, P.2
Toutans, C.3
-
18
-
-
0029932699
-
Nutritional support to prevent and treat multiple organ failure
-
Bengmark S, Gianotti L. Nutritional support to prevent and treat multiple organ failure. World J Surg. 1996;20:474-81
-
(1996)
World J Surg
, vol.20
, pp. 474-481
-
-
Bengmark, S.1
Gianotti, L.2
-
21
-
-
0021864017
-
Long-term follow-up of patients with Crohn's disease: Relationship between the clinical pattern and prognosis
-
Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease: Relationship between the clinical pattern and prognosis. Gastroenterology. 1985;88:1818-25.
-
(1985)
Gastroenterology
, vol.88
, pp. 1818-1825
-
-
Farmer, R.G.1
Whelan, G.2
Fazio, V.W.3
-
23
-
-
0032706660
-
Hyperbaric oxygen as adjunct therapy for crohn's intractable enteric ulcer
-
Takeshima F, Makiyama K, Doi T. Hyperbaric oxygen as adjunct therapy for crohn's intractable enteric ulcer. Am J Gastroenterol. 1999;94:3374-5.
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 3374-3375
-
-
Takeshima, F.1
Makiyama, K.2
Doi, T.3
-
24
-
-
0028120510
-
Hyperbaric oxygen for perianal Crohn's disease
-
Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S; Hyperbaric oxygen for perianal Crohn's disease. J Clin Gastroenterol. 1994;19:202-5.
-
(1994)
J Clin Gastroenterol
, vol.19
, pp. 202-205
-
-
Lavy, A.1
Weisz, G.2
Adir, Y.3
Ramon, Y.4
Melamed, Y.5
Eidelman, S.6
-
25
-
-
58149296153
-
The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis
-
Ercin CN, Yesilova Z, Korkmaz A, Ozcan A, Oktenli C, Uygun A. The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis. Dig Dis Sci. 2009;54:75-9.
-
(2009)
Dig Dis Sci
, vol.54
, pp. 75-79
-
-
Ercin, C.N.1
Yesilova, Z.2
Korkmaz, A.3
Ozcan, A.4
Oktenli, C.5
Uygun, A.6
|